Study of Longidaze in the Prevention & Treatment of Pulmonary Fibrosis, Interstitial Lung Diseases Caused by COVID-19

CompletedOBSERVATIONAL
Enrollment

160

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

April 20, 2022

Study Completion Date

April 20, 2022

Conditions
Fibroses, Pulmonary
Interventions
DRUG

bovhyaluronidase azoxymer

3000 IU intramuscularly once every 5 days with a course of 15 injections

Trial Locations (15)

105229

"FSBI Main Military Clinical Hospital named after Academician N.N.Burdenko of the Ministry of Defense of the Russian Federation", Moscow

125222

"State Budgetary Institution of Healthcare of the City of Moscow City Polyclinic No. 180 of the Department of Healthcare of the City of Moscow", Moscow

194354

"St. Petersburg State Budgetary Healthcare Institution City Consultative and Diagnostic Center No. 1", Saint Petersburg

350042

"Medical center Clinic South", Krasnodar

400065

"State health care institution Clinical Hospital No. 4", Volgograd

400131

"Federal State Budgetary Educational Institution of Higher Education Volgograd State Medical University of the Ministry of Health of the Russian Federation Volgograd State Medical University of the Ministry of Health of Russia", Volgograd

414000

"Federal State Budgetary Educational Institution of Higher Education Astrakhan State Medical University of the Ministry of Health of the Russian Federation", Astrakhan

450005

State budgetary institution of health care Republican clinical hospital named after G.G. Kuvatova, Ufa

454007

"Municipal autonomous health care institution City Clinical Polyclinic No. 8", Chelyabinsk

454021

"State Budgetary Healthcare Institution Regional Clinical Hospital No. 3", Chelyabinsk

614107

"CJSC Medical Center Philosophy of Beauty and Health ", Perm

620149

"Municipal budgetary institution Central city clinical hospital number 6 ", Yekaterinburg

630087

State Novosibirsk Regional Clinical Hospital, Novosibirsk

660022

"Federal State Budgetary Scientific Institution Federal Research Center Krasnoyarsk Scientific Center of the Siberian Branch of the Russian Academy of Sciences Scientific Research Institute of Medical Problems of the North", Krasnoyarsk

660133

Institute of Clinical Immunology LLC, Krasnoyarsk

All Listed Sponsors
lead

NPO Petrovax

INDUSTRY

NCT04645368 - Study of Longidaze in the Prevention & Treatment of Pulmonary Fibrosis, Interstitial Lung Diseases Caused by COVID-19 | Biotech Hunter | Biotech Hunter